India: Gland Pharma investors mulling 74% stake sale to Fosun in alternative plan

India: Gland Pharma investors mulling 74% stake sale to Fosun in alternative plan

The shareholders of Gland Pharma Ltd, including buyout firm KKR and Co., are considering selling a stake of up to 74% under the automatic approval route to China’s Fosun International after failing to secure government approval for an 86% stake sale so far, two people aware of the discussions said.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter